Clinigence Holdings, Inc.
CLNH
Other OTC6.40
USD
- -
- -
CIK
0001479681
ISIN
US18727D1054
CUSIP
18727D105
Return %
Stock
S&P500
1Y
- -
18.21
3Y
- -
64.38
5Y
29.29
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Warren Hosseinion
- Full Time Employees
- 12
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 55 Ivan Allen Jr. Boulevard NW Atlanta GA United States of America 33304
- IPO Date
- Jan 8, 2021
- CIK
- 0001479681
- Website
- ahahealthcare.net
- Similar Companies
- Business
- Clinigence Holdings, Inc. (OTC: CLNH) operates as a technology-enabled healthcare services company focused on population health management and value-based care solutions. The company provides an advanced cloud-based platform that aggregates clinical and claims data across multiple settings, information systems, and sources to deliver holistic patient and provider insights; offers Medicare management, performance metrics, cost improvement plans, performance improvement services, and health management programs; and supports payer and provider organizations through analytics-driven software including predictive and prescriptive analytics, clinical quality measure (CQM) and electronic clinical quality measure (eCQM) reporting, machine learning, natural language processing, generative AI capabilities, and data insights for value-based care via its QMX platform. Incorporated in 2014 and headquartered in Fort Lauderdale, Florida, Clinigence Holdings serves healthcare organizations such as payers, providers, independent physician associations (IPAs), accountable care organizations (ACOs), and management services organizations (MSOs), with data processing for over 118 organizations, 20,791 practices, 5.9 million patients, 21,131 providers, and 24 payers as of 2024. The company targets the U.S. healthcare market, emphasizing the transition from fee-for-service to risk-bearing and full-risk global capitation models. In recent developments, Clinigence Holdings completed a merger with Nutex Health in April 2022, forming Nutex Health Inc. (NASDAQ: NUTX), a physician-led integrated care provider with hospital and population health management divisions, though Clinigence continues to trade separately on OTC markets; received a $3 million equity investment from Apollo Medical Holdings, Inc. in 2022, issuing shares and warrants while adding a board member; and acquired ProCare Health, a California-based MSO, along with Accountable Healthcare America (AHA) and AHP Management to enhance population health management, MSO capabilities, and medical group operations. These strategic moves, including prior acquisitions of AHA and AHP that renamed operations under Accountable Healthcare America, positioned the company for Nasdaq uplisting pursuits and expanded its technology-enabled services for micro-hospitals, specialty hospitals, and provider networks. As of October 2025, the company secured a Nasdaq compliance extension to December 12, 2025, for filing overdue reports.
7 OTC Stocks That Made It Big in 2021 for Multiple Reasons